calendar
4,370 catalysts · 3,230 8k filing · 577 earnings · 184 grant · 172 phase 2 completion · 133 drug shortage · 128 approval
next 91 dayslessmore
MonWedFri
4,370 catalysts · 3,230 8k filing · 577 earnings · 184 grant · 172 phase 2 completion · 133 drug shortage · 128 approval
Status: Current. Reason: not specified. Form: Injection
Status: To Be Discontinued. Reason: not specified. Form: Capsule
Status: Current. Reason: not specified. Form: Injection
Status: Current. Reason: not specified. Form: Injection
Status: Current. Reason: not specified. Form: Injection
Status: Current. Reason: not specified. Form: Injection
Status: Current. Reason: not specified. Form: Injection
Vanilla Bourbon Trail Mix
Items: 7.01, 9.01
Items: 5.02, 7.01, 9.01
Items: 1.01, 8.01, 9.01
Items: 7.01, 8.01, 9.01
Items: 5.02, 9.01
Items: 5.02, 9.01
Items: 1.02
Items: 8.01
Items: 8.01
Items: 2.02, 7.01, 9.01
Items: 5.02
Items: 5.02, 5.07, 9.01
Items: 7.01, 8.01, 9.01
Items: 5.02, 7.01, 9.01
Items: 2.02, 9.01
Items: 8.01
Items: 7.01, 9.01
Items: 1.01, 7.01, 8.01, 9.01
Items: 5.02, 7.01, 9.01
Items: 7.01, 9.01
Items: 1.02, 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, 9.01
Therapy area: Infectious Disease, Respiratory. Indication: Asthma, Influenzavirus A Infections, Influenzavirus B Infections
Therapy area: Gastrointestinal, Infectious Disease, Oncology. Indication: Acral Lentiginous Melanoma, Adenocarcinoma Of The Gastroesophageal Junction, Adenoid Cystic Carcinoma (ACC), Adrenocortical Carcinoma (Adrenal Cortex Cancer), Anaplastic Thyroid Cancer, Bile Duct Cancer (Cholangiocarcinoma), Bladder Cancer, Breast Cancer, Colorectal Cancer, Cutaneous Squamous Cell Carcinoma (cSCC), Endometrial Cancer, Ependymoma, Epithelial Ovarian Cancer, Esophageal Squamous Cell Carcinoma (ESCC), Ewing S
Therapy area: Infectious Disease, Respiratory. Indication: Asthma, Influenzavirus A Infections, Influenzavirus B Infections
Therapy area: Gastrointestinal, Infectious Disease, Oncology. Indication: Acral Lentiginous Melanoma, Adenocarcinoma Of The Gastroesophageal Junction, Adenoid Cystic Carcinoma (ACC), Adrenocortical Carcinoma (Adrenal Cortex Cancer), Anaplastic Thyroid Cancer, Bile Duct Cancer (Cholangiocarcinoma), Bladder Cancer, Breast Cancer, Colorectal Cancer, Cutaneous Squamous Cell Carcinoma (cSCC), Endometrial Cancer, Ependymoma, Epithelial Ovarian Cancer, Esophageal Squamous Cell Carcinoma (ESCC), Ewing S
Therapy area: Undisclosed. Indication: Unspecified
Therapy area: Oncology. Indication: Solid Tumor
Therapy area: Dermatology, Immunology. Indication: Atopic Dermatitis (Atopic Eczema), Plaque Psoriasis (Psoriasis Vulgaris), Systemic Lupus Erythematosus
Therapy area: Hematological Disorders, Infectious Disease, Oncology. Indication: Aplastic Anemia, Cytomegalovirus (HHV-5) Infections, Hemophagocytic Lymphohistiocytosis, Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma), Refractory Acute Myeloid Leukemia, Viral Infections
Therapy area: Women's Health. Indication: Endometriosis
Therapy area: Women's Health. Indication: Endometriosis
Therapy area: Central Nervous System, Ear Nose Throat Disorders. Indication: Pain, Rhinosinusitis
Therapy area: Central Nervous System. Indication: Anxiety Disorders, Post-Traumatic Stress Disorder (PTSD)
Therapy area: Oncology. Indication: Anaplastic Astrocytoma, Glioblastoma Multiforme (GBM), High-Grade Glioma, Low-Grade Astrocytoma, Malignant Glioma, Oligodendroglioma
Therapy area: Oncology. Indication: Colorectal Cancer, Metastatic Colorectal Cancer
Therapy area: Central Nervous System. Indication: Delirium
Therapy area: Dermatology. Indication: Androgenic Alopecia
Therapy area: Genito Urinary System, Immunology. Indication: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis), Glomerulonephritis, Kidney Fibrosis
Therapy area: Central Nervous System. Indication: Anxiety Disorders, Insomnia, Pain
Therapy area: Oncology. Indication: Rectal Cancer
Therapy area: Nutritional Disorders. Indication: Hyperphosphatemia
Therapy area: Metabolic Disorders. Indication: Obesity